LCDActive
Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
L39877
First Coast Service Options, Inc. (J09)
Effective: December 1, 2024
Updated: December 31, 2025
Policy Summary
This policy states that all injections and/or applications of amniotic membrane, amniotic fluid, and other placental-derived products for musculoskeletal indications are not covered as not reasonable and necessary. The non-coverage explicitly includes tendon/ligament injuries, cartilage damage, osteoarthritis, joint and back pain, chronic pain, and adjunctive orthopedic surgical uses; dental uses are also excluded. Burns, wounds, and ophthalmic uses are outside the scope of this policy and may be addressed separately.
Coverage Criteria Preview
Key requirements from the full policy
"All amniotic membrane, amniotic fluid, or other placental-derived product injections and/or applications for the treatment of any musculoskeletal condition are not covered as not reasonable and nec..."
Sign up to see full coverage criteria, indications, and limitations.